The WMS has provided advice for people with neuromuscular disorders, and their healthcare providers since the start of the COVID-19 pandemic. This is a document aiming to answer questions regarding the newly developed vaccines against Coronavirus SARS-CoV2 asked by people with neuromuscular disorders. This is a rapidly developing field, and the WMS will keep this advice in regular review.
Click here to read WMS advice on Covid-19 and people with neuromuscular disorders
Disclaimer: WMS members have contributed to the translation of the original document into various languages. WMS assumes that all the translated content is true and accurate to the English original.
Published on 23 April 2022.
26 Mar 2024 Sustainability at the WMS
23 Nov 2023 WMS student member launches survey looking at neuromuscular genetic testing in clinical practice
24 Oct 2023 Phishing email scams that seem to be coming from WMS President
